ICU, Medegen Settle IV Connection Patent Spat
The companies filed a stipulated dismissal Tuesday in the U.S. District Court for the Central District of California, dismissing the original complaint and counterclaims without prejudice and agreeing to bear their own costs.
“ICU Medical and Medegen are pleased to shift their focus from the litigation to their business relationship,” the companies said in a Tuesday statement.
Further information on the settlement was...
To view the full article, register now.